Cardiac Imaging: Page 21

OneProjects raises $17M to launch imaging platform

By AuntMinnie.com staff writers

OneProjects has raised a total of $17 million in a new financing round to fund the launch of its proprietary 4D cardiac imaging platform, Verafeye.

October 13, 2021

Cardiac MRI is 'technique of choice' for imaging suspected heart tumors

By Kate Madden Yee

Cardiac MRI is the "technique of choice" for imaging suspected cardiac tumors, with a high accuracy rate and prognostic value, according to a study published September 21 in the European Heart Journal.

October 7, 2021

FDA signs off on change to contraindications for GE's Optison agent

By AuntMinnie.com staff writers

The U.S. Food and Drug Administration (FDA) has approved the removal of hypersensitivity to blood and blood products from the listed contraindications for GE Healthcare's Optison echocardiography contrast agent.

October 4, 2021

Are radiologists regaining control of cardiac imaging?

By Kate Madden Yee

The rate of coronary CT angiography exams performed by radiologists in U.S. hospitals increased by more than 300% between 2010 and 2019, indicating that radiologists could be regaining control of cardiac imaging, according to a September 30 paper in Radiology: Cardiothoracic Imaging.

September 30, 2021

GE rolls out MyoSPECT cardiac nuclear medicine scanner

By AuntMinnie.com staff writers

GE Healthcare is rolling out a new dedicated nuclear medicine scanner called MyoSPECT. The system sports an extended field of view and automated workflow, as well as detectors based on digital cadmium zinc telluride technology.

September 29, 2021

PET links heart disease risk and PTSD

By Will Morton

PET imaging has found a link between heart disease risk and post-traumatic stress disorder (PTSD) in Vietnam War veterans, according to a study published September 27 in Biological Psychiatry.

September 28, 2021

Zebra Medical wins FDA nod for CAC analysis software

By AuntMinnie.com staff writers

Artificial intelligence (AI) software developer Zebra Medical Vision has received U.S. Food and Drug Administration (FDA) 510(k) clearance for HealthCCSng, an AI-based software application for analysis of coronary artery calcium (CAC) on nongated CT studies.

September 26, 2021

PET detects activity in early atherosclerosis

By Will Morton

PET imaging has shown that an experimental radiotracer can detect cellular activity in the artery walls of patients with atherosclerosis, according to a study published September 18 in the Journal of Nuclear Medicine.

September 20, 2021

New studies show how CT reveals 'silent' atherosclerosis

By Will Morton

Atherosclerosis progresses undetected and is known as the silent killer. But cardiac CT can identify early signs of the disease in healthy people -- an important new finding for developing strategies to prevent it, according to studies published September 20 in the journals Circulation and Heart.

September 19, 2021

Cardiac PET predicts outcomes in aortic stenosis

By Will Morton

PET imaging has shown how impaired blood flow in small vessels of the heart may lead to myocardial stress and injury in patients with aortic stenosis, according to a study published online September 15 in JAMA Cardiology.

September 15, 2021

Us2.ai secures FDA nod for echocardiography AI software

By AuntMinnie.com staff writers

Artificial intelligence (AI) software developer Us2.ai has secured U.S. Food and Drug Administration (FDA) clearance for its Us2.v1 echocardiography image analysis software.

September 13, 2021

HeartFlow revenues surge in Q2

By AuntMinnie.com staff writers

Strong demand for its products helped cardiovascular software developer HeartFlow to more than double its revenues in its second quarter, according to preliminary financial results.

September 13, 2021

Previous Page

Page 21 of 323

Next Page